Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,447 public trials 2,856 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Not yet recruiting

Efficacy and Safety of CD7 CAR-T in Newly Diagnosed High-Risk T-LBL/ALL

NCT07476027

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Not specified

View Trial Details

Not yet recruiting

BLOOD-dose: A Platform Trial Evaluating Dose Optimization in Hematological Diseases.

NCT07474961

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Copenhagen University Hospital - Rigshospitalet Copenhagen, Greater Copenhagen Area, Denmark

Aalborg University Hospital Aalborg, Denmark

Aarhus University Hospital Aarhus, Denmark

Odense University Hospital Odense, Denmark

View Trial Details

Not yet recruiting

Quality of Life in Pediatric Participants With HHT

NCT07474428

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +10 more
Locations: Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

View Trial Details

Not yet recruiting

Gecacitinib Pre-, During- and Post-HSCT for Patients With Primary or Secondary Myelofibrosis

NCT07471503

Conditions: Bone Marrow Diseases, HSCT, Hematologic Diseases, +4 more
Locations: Not specified

View Trial Details

Not yet recruiting

GRanulocyte Augmented Cord Blood Transplantation for Poor Risk leukaEmia

NCT07372885

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Cellular Therapy, +11 more
Locations: Kings College Hospital NHS Trust London, United Kingdom

The Royal Marsden Hospital NHS Foundation Trust London, United Kingdom

The Christie NHS Foundation Trust Manchester, United Kingdom

View Trial Details

Not yet recruiting

Study Evaluating the Efficacy and Safety of the Addition of Ivosidenib to Oral Azacitidine (Onureg®) in Patients Over 55 With Acute Myeloid Leukemia (AML) and IDH1 Mutation, in Complete Remission After Intensive Chemotherapy.

NCT07463768

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: CHU Angers Angers, France

CH côte Basque Bayonne, France

CHU Besançon Besançon, France

Hopital d'Instruction des Armées Percy Clamart, France

View all 20 locations

View Trial Details

Not yet recruiting

The Influence of Anemia on HbA1c Readings in Non-Diabetic Patients

NCT07463612

Conditions: Anemia, HbA1c, Hematologic Diseases, +1 more
Locations: Sohag University Hospitals Sohag, Sohag Governorate, Egypt

View Trial Details

Not yet recruiting

Nemtabrutinib, Bortezomib, and Rituximab for WM

NCT07464210

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Not yet recruiting

NUDT15/TPMT Multi-gene Guided 6-MP Dosing in Childhood ALL Maintenance Therapy

NCT07462299

Conditions: Childhood Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: The Children's Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Not yet recruiting

Tranexamic Acid for Bleeding Reduction During TURP Surgery

NCT07460518

Conditions: Anemia, Anemia, Postoperative, Benign Prostatic Hyperplasia, +10 more
Locations: Mohammed V Military Teaching Hospital Rabat, Morocco

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions